Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Works of Jeffrey A. Bubis being referenced
DKN-01 plus bevacizumab and chemotherapy as second-line (2L) investigational therapy in advanced microsatellite stable (MSS) colorectal adenocarcinoma (CRC): DeFianCe trial.
2024
Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jeffrey A. Bubis | 78 | 268 | 29 | 225 | 135 | 14 | 380 | |
| H C Hsu | 71 | 100 | 55 | 63 | 146 | 15 | 401 | |
| Bukowski Rm | 59 | 111 | 50 | 73 | 48 | 18 | 424 | |
| L F Sheu | 25 | 168 | 65 | 62 | 153 | 13 | 348 | |
| Baozhen Ke | 183 | 87 | 15 | 24 | 192 | 12 | 444 | |
| Christina Alidousty | 101 | 116 | 46 | 28 | 208 | 18 | 399 | |
| Chikako Segawa | 34 | 112 | 13 | 39 | 35 | 10 | 417 | |
| Hejing Huang | 26 | 222 | 36 | 26 | 101 | 15 | 358 | |
| Chun‐Jung Chang | 100 | 132 | 29 | 43 | 65 | 15 | 338 | |
| Yasmin Alam | 203 | 298 | 28 | 84 | 111 | 8 | 451 | |
| Katja Matthes | 48 | 233 | 54 | 28 | 89 | 18 | 362 |
All Works
Loading papers...